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Introduction
Despite recent technical advances in aortic arch sur-
gery, neurological complications are still a major con-
cern. Because of its simplicity, hypothermic circulatory
arrest (HCA), with or without retrograde cerebral
perfusion, has been widely adopted as an adjunct to
prevent ischemic cerebral injury.1,2 However, its use is
limited by the duration of the procedure, so some sur-
geons prefer to use selective cerebral perfusion (SCP)
when prolonged ischemia is anticipated.3,4 A specific,
quantitative, and predictive biochemical marker of
brain injury would help to clarify the advantages and
limitations of these three adjuncts.
S-100b protein (S100b), which is found predomi-
nantly in glial and Schwann cells, is thought to be a
specific biochemical marker for brain injury.5 However,
the early increase in serum S100b during cardiopulmo-
nary bypass (CPB) is unlikely to be associated with
clinically detectable brain injury.6 Extracerebral con-
tamination,7,8 increased permeability of the blood–brain
barrier (BBB) related to inflammatory responses,9–11
and changes in the rate of elimination through the
kidneys may explain this discrepancy.12
Raabe et al. found that S100b levels in the jugular
vein were significantly higher than the arterial levels in
patients with severe head injury.13 Therefore, measuring
the S100b levels in the jugular vein may help to clarity
the origin of S100b in patients undergoing CPB. How-
ever, to our knowledge no study on the jugular vein
levels of S100b in patients undergoing CPB or SCP has
been published.
Abstract
Purpose. The early increase in serum S100b after car-
diopulmonary bypass (CPB) seems to be derived from
an extracerebral source. To exclude contamination, we
investigated the arterio-jugular differences in S100b
levels in patients receiving selective cerebral perfusion
(SCP). We also evaluated the brain-protective effect of
SCP by comparing the arterial S100b levels with those
in patients undergoing coronary artery bypass grafting
(CABG).
Methods. We measured arterial and jugular venous
levels of S100b in ten patients undergoing aortic arch
repair with SCP for up to 12h postoperatively (SCP
group). We also measured arterial levels of S100b in
nine patients undergoing CABG (CPB group).
Results. There was no incidence of hospital death or
stroke. The arterial levels of S100b in both groups were
comparable and peaked just after the conclusion of
CPB. The arterial and jugular venous levels of S100b
were almost equivalent. The arterio-jugular differences
in S100b levels were negligible, even in our SCP-group
patient with postoperative delirium, who had a peak
value three times higher than the other patients.
Conclusions. The arterio-jugular differences in S100b
did not clarify the origin of their increase. Thus, measur-
ing the jugular venous levels of S100b in patients with-
out postoperative clinical neurological deterioration
would be of little benefit. However, SCP seems to pro-
tect the brain against S100b release as effectively as
conventional CPB.
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We investigated the arterio-jugular differences in
S100b levels to exclude extracerebral contamination in
patients undergoing SCP. We also evaluated the protec-
tive effect of SCP by comparing arterial S100b levels




Ten patients undergoing reconstruction of the aortic
arch or ascending aorta with SCP were enrolled in this
study (SCP group). All patients underwent elective sur-
gical repair at Hokkaido University Hospital during the
year between May 1999 and May 2000. We obtained
approval from the institutional review board and
written informed consent was given by all patients. The
underlying diseases were chronic aortic dissection in
four patients (one of whom had a pseudoaneurysm)
and nondissection degenerative disease in six patients.
The operations performed were replacement of the as-
cending aorta in one patient, hemiarch replacement
in three patients, and total aortic arch replacement in
five patients, two of whom underwent one-vessel
CABG. Distal anastomosis of the CABG was done
during core cooling. One patient underwent refixation
of a sent graft in the distal arch. Three patients had
undergone previous aortic surgery for other lesions;
in the thoracoabdominal aorta in one and in the ab-
dominal aorta in two. One patient with an old cerebral
infarction resulting in aphasia had also undergone
cerebral aneurysm repair (coating procedure) 3 years
earlier.
As a control, we enrolled ten patients who underwent
elective CABG with CPB during the same period (CPB
group). One patient, who had the highest S100 level
(5.17mg/l) just after the conclusion of CPB, was
excluded following the development of renal insuffi-
ciency receiving hemodialysis. The number of distal
anastomoses was 3.8 ± 1.1 and a side-biting clamp
was applied to the ascending aorta in all patients.
One patient underwent concomitant left ventricular
aneurysmectomy and another had a history of transient
ischemic attack.
There were no significant differences between the
two groups in age, gender, height, body weight, preop-
erative serum creatinine (Cr) levels, or Cr-clearance
levels (Table 1).
Anesthesia, Operative Methods, and Adjuncts
All patients received standard general anesthesia using
neuromuscular blockade and intermittent intravenous
fentanyl. All operations were performed through a mid-
line sternal incision. We described our operative meth-
ods of aortic arch replacement in detail previously.4
Briefly, systemic perfusion cooling was done through an
arterial return cannula placed in the proximal ascending
aorta in four patients, in the aortic arch in two, in the
brachiocephalic artery in one, and in the femoral artery
in three. When the rectal temperature had dropped
22°C, selective cerebral perfusion of the three arch ves-
sels was established. All three arch vessels were cannu-
lated directly in three patients, and perfused through a
balloon catheter introduced via the aortic arch in two
patients. In the other five patients, the brachiocephalic
artery and the left common carotid artery were
cannulated directly and the left subclavian artery was
perfused through a balloon catheter. The initial total
flow for the SCP was 683.3 ± 66.0 ml/min (11.3 ± 1.4ml/
min per kg). The pressures in the bilateral radial arteries
and left superficial temporal artery were continuously
monitored to keep the latter around 50mmHg during
SCP. We performed open distal aortic anastomosis first,
followed by systemic reperfusion through the side
branch of the prosthesis, then proximal aortic anasto-
mosis to shorten the duration of myocardial ischemia.
Finally, we connected the arch vessels to the branches of
the prosthesis during the rewarming phase. When con-
comitant CABG was done, the distal anastomosis was
performed during cooling and the proximal anastomosis
was performed after the completion of SCP using a side-
biting clamp. The autologous saphenous vein was used
as the conduit for CABG.
The system for CPB consisted of a heparin-coated
circuit (Terumo, Tokyo, Japan), a centrifugal pump
(Medtronic Bio-Medicus, Eden Prairie, MN, USA),
and a membrane oxygenator (Capiox SX-18; Terumo).
We did not use an arterial filter. This system was
primed with lactated Ringer’s solution with 5mg/kg
betamethasone added. The same dose of beta-
methasone was given intravenously before starting
CPB. To prime the circuit for SCP, the initial dilution
ratio in the SCP group was significantly larger than that
in the CPB group, at 22.1% ± 4.4% vs. 15.3% ± 3.0%
(P = 0.0063), but there was no significant difference in
the final dilution ratio (30.1% ± 11.7% vs 21.9% ±
9.9%). The alpha-stat strategy was applied during CPB.
A cardiotomy sucker and a centrifugal cell-saving de-
vice (Cell Saver 5, Haemonetics, Braintree, MA, USA)
were used in all patients, but washed red blood cells
(RBC) were returned during the operation in only
five patients. Postoperative shed mediastinal blood was
discarded.
Coronary artery bypass grafting was performed using
standard techniques. We used an average of 2.3 ± 0.9
arterial conduits for CABG. The left internal thoracic
artery was used in eight patients (concomitantly with
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the right internal thoracic artery in one), the left radial
artery in eight, and the right gastroepiploic artery in
four. An average of 0.3 ± 0.5 autologous saphenous vein
grafts were also used (n = 3). Instead of betamethasone,
1 000mg methylprednisolone was administered in both
the CPB circuit and the systemic circulation in five pa-
tients. We gave 250 mg methylprednisolone to the other
four patients.
Measurement of S100b Protein
Using a percutaneous retrograde approach, a 4-F
oximetric catheter (Opticath, Abbott Laboratories,
Abbott Park, IL, USA) was placed in the right internal
jugular venous bulb through a 5.5-F sheath in the SCP
group. We collected samples of whole blood from the
radial artery or CPB circuit (only at T1–T3), and from
the internal jugular vein in the SCP group at the follow-
ing seven time points: just before and after the initiation
of CPB (T0, T1), just before systemic circulatory arrest
(T2), 1 h after the onset of SCP (T3), just after the
conclusion of CPB (T4), just after skin closure (T5), and
12 h after surgery (T6). In the control, T2 was omitted
and T3 was substituted by 1 h after aortic cross-
clamping (AXC). Blood samples were centrifuged in an
Eppendorf centrifuge and the supernatant was separated
for immediate freezing at -80°C for later measurements
during April and May 2000. This method of storage
would not influence the measurements of S100b (This
is communication with Sangtec Medical, Bromma,
Sweden). The serum levels of S100b were measured in
duplicate using a commercially available two-site im-
munoradiometric assay kit (Sangtec Medical, Bromma,
Sweden). The minimun detectable level was 0.2mg/l.
Statistical Analysis
All values are expressed as mean ± standard deviation
(SD). We used the paired t-test for statistical analysis of
time-related data and the unpaired t-test for compari-
sons between the groups. The chi-square test was used
for comparison of frequencies. All statistical analyses
were done by procedures in StatView 5.0 for Macintosh
(SAS Institute, Cary, NC, USA). A P value of less than
0.05 was considered significant.
Results
The patients in the SCP group were all men, ranging in
age from 60 to 80 years old (mean 71.7 ± 5.9 years), and
the control group consisted of seven men and two
women, ranging in age from 55 to 86 years old (mean
64.9 ± 9.9 years).
There was no incidence of hospital death or stroke.
One 79-year-old man in the SCP group suffered tempo-
rary delirium. All patients, except for one, were weaned
off mechanical ventilation within 24h after surgery. One
patient required mechanical ventilation for 2 days.
There were no complications related to cannulation of
the internal jugular vein. There were no significant dif-
ferences between the two groups in the mean operative,
CPB, or AXC times (Table 1). The mean operative,
CPB, AXC, SCP, and HCA times for the patient with
postoperative delirium were 454, 242, 50, 88, and 33 min,
respectively. There were no significant differences
between the two groups in intraoperative blood loss,
transfused banked red blood cells (RBC), returned au-
tologous washed RBCs, or the highest postoperative
Table 1. Patient characteristics including operative data
SCP group CPB group P value
Age (years) 71.7 ± 5.9 64.9 ± 9.9 0.0835
Height (cm) 167.3 ± 6.7 163.1 ± 11.0 0.3298
Body weight (kg) 60.7 ± 7.7 63.2 ± 15.4 0.6569
Operation time (min) 528 ± 208 438 ± 130 0.2836
CPB time (min) 227 ± 49 194 ± 48 0.1606
AXC time (min) 100 ± 45 119 ± 25 0.3029
SCP time (min) 125 ± 52
HCA time (min) 65 ± 35
Lowest RT (°C) 18.6 ± 2.2 33.1 ± 0.7 <0.0001
Blood loss (ml) 471 ± 314 680 ± 853 0.4796
Transfused banked RBC (ml) 824 ± 1246 (n = 5) 576 ± 516 (n = 8) 0.5857
Washed RBC return (ml) 456 ± 909 (n = 5) 194 ± 226 (n = 3) 0.5043
Preoperative Ccr (mg/ml/min) 70.8 ± 21.4 59.0 ± 37.3 0.4103
Preoperative Cr (mg/dl) 1.0 ± 0.3 1.0 ± 0.5 0.8949
Postoperative highest Cr (mg/dl) 1.3 ± 0.6 1.0 ± 0.4 0.3028
Data are expressed as mean ± standard deviation
CPB, cardiopulmonary bypass; AXC, aortic cross-clamping; SCP, selective cerebral perfusion; HCA, hypothermic circulatory arrest; RT, rectal
temperature; Blood loss, intraoperative blood loss; Transfused banked RBC, intraoperative homologous red blood cell transfusion; Washed RBC
return, intraoperative washed autologous red blood cell return; Ccr, creatinine clearance level; Cr, serum creatinine level
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serum Cr level (Table 1). These respective amounts in
the patient with postoperative delirium were 390ml,
560ml, 383 ml, and 1.6mg/dl.
The arterial S100b levels increased gradually after T1
and peaked at T4 in both groups (Fig. 1). They were
significantly higher than the levels at T0, from T2 to T4
in the SCP group and from T1 to T6 in the CPB group.
The arterial S100b levels in the SCP group were slightly
higher than those in the CPB group at all times, but the
differences were not significant.
The patient with delirium had the highest arterial
S100b level in the SCP group at T3 and T4. His jugular
venous S100b level was also slightly higher than his
arterial level at T3 and T6. The mean arterial S100b
levels in the other nine patients were almost equivalent
to the jugular venous levels throughout the observation
period. Thus, there were no significant differences be-
tween them at any time (Fig. 2).
Discussion
To our knowledge, this is the first study to evaluate the
arterio-jugular differences in S100b levels in patients
undergoing SCP. During SCP and reperfusion, the jugu-
lar venous S100b levels were almost equivalent to the
arterial S100b levels in patients without any postopera-
tive neurological deficit. Even in the patient with post-
operative delirium, who had the highest S100b peak
level, the arterio-jugular differences in S100b was not as
great as one might expect. Moreover, the arterial S100b
levels in the SCP group were comparable with those in
the CPB group.
These findings suggest that the arterio-jugular differ-
ences in S100b levels provide little beneficial informa-
tion about patients without postoperative irreversible
neurological injury after SCP; however, they have been
reported to be a useful marker of brain injury in patients
with severe head injury.13 There are two possible expla-
nations for this. First, recirculation equilibrates the
concentrations so quickly that even a significant release
of S100b would create only a subtle difference in the
arterio-jugular concentration. Although none of the
patients in our series suffered postoperative stroke, it
would be interesting to investigate the arterio-jugular
differences in S100b levels in such patients. Second, our
method of SCP provides sufficient brain protection that
the S100b release from the brain would be minimal.
Since brain metabolism was thoroughly depressed at
the lowest rectal temperature of 18.6° ± 2.2°C, the total
flow of the SCP of 11.3 ± 1.4 ml/min per kg might be
more than adequate for cerebral metabolic demand.
Our previous study using near-infrared spectrophotom-
etry and jugular venous oxygen saturation clearly dem-
onstrated this.14 Recent studies found higher serum
S100b levels in patients with HCA than in those without
HCA.15–17 Therefore, our result reinforces the advan-
tages of SCP. Although Svensson and colleagues re-
ported that the serum S100b levels in patients given
HCA were not different from those in patients given
SCP,17 this inconsistency may be explained by the differ-
ence in perfusion conditions.
Fig. 1. Comparison of the time course of arterial S-100b pro-
tein levels between patients undergoing selective cerebral per-
fusion (open circles; SCP group, n = 10) and those undergoing
coronary artery bypass grafting (closed circles; CPB group, n =
9). Data are expressed as mean ± standard deviation T0, T1,
just before and after the initiation of CPB; T2, just before
systemic circulatory arrest; T3, 1 h after the onset of SCP; T4,
just after the conclusion of CPB; T5, just after skin closure; T6,
12 h after surgery. In the control, T2 was omitted and T3 was
substituted by 1h after aortic cross-clamping
Fig. 2. Comparison of the time course of serum S-100b
protein levels between a 79-year-old man with postoperative
temporal delirium (circles) and nine patients with normal
postoperative neurological status (squares) during and after
selective cerebral perfusion. Each open circle or open square
represents a sample from the artery, whereas each closed
circle or closed square represents a sample from the internal
jugular vein. Data are expressed as mean ± standard devia-
tion. T0, T1, just before and after the initiation of CPB; T2,
just before systemic circulatory arrest; T3, 1 h after the onset
of SCP; T4, just after the conclusion of CPB; T5, just after skin
closure; T6, 12 h after surgery. In the control, T2 was omitted
and T3 was substituted by 1h after aortic cross-clamping
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The fact that the patient with postoperative delirium
had a threefold higher S100b peak level than the other
patients supports the possibility that S100b is a marker
of brain injury. Moreover, the result that S100b leakage
during SCP was comparable with that during CPB sug-
gests that our current technique of SCP protects the
brain effectively. Although the arterial S100b levels in
the SCP group were slightly higher than those in the
CPB group, they were already higher at T0 in the SCP
group than before CPB in the CPB group. Bhattacharya
et al. found slightly increased preoperative serum S100b
levels in patients with acute aortic dissection.15 None of
the patients in this series had acute aortic dissection,
although the four patients with chronic aortic dissection
had slightly higher arterial S100b levels than the six
patients without aortic dissection in the SCP group (0.93
± 0.93 vs 0.53 ± 0.39, P = 0.3693).
The arterial S100b levels in both groups increased
gradually during CPB and peaked just after the con-
clusion of CPB, followed by a gradual decrease. This
trend is similar to findings reported by many research-
ers.15–20 The underlying mechanism of this gradual eleva-
tion is multifactorial. Reversible injury of the Schwann
cells and glial cells increases the permeability of the
BBB,9–11 and extracerebral contamination7,8 may also
play a role. Although S100b is an unquestionable
marker of brain injury,5,6 it is still unclear why S100b
increases during CPB without neurologic sequelae.
Cerebral microemboli were found to be associated with
neurocognitive dysfunction21 and significantly corre-
lated with the S100b level18 after cardiac surgery. There-
fore, subclinical brain injury may be responsible for the
gradual elevation in S100b during CPB. This specula-
tion is supported by reports that S100b release is well
correlated with neuropsychological function8,22 and is
attenuated by arterial line filtration.19 Second, the in-
creased permeability of BBB, which is related to the
inflammatory responses caused by CPB, may accelerate
S100b leakage through the BBB.9–11 This phenomenon,
recognized as postoperative cerebral edema, develops
predominantly in the white matter of the brain, where
most Schwann cells and glial cells are found.6 Thus, it
has been reported that S100b elevation is correlated
with the duration of CPB,16,18,20,22 which may explain why
the S100b value increases gradually during CPB. The
contribution of these two factors to gradual S100b el-
evation during CPB is confirmed by the reduced S100b
release during off-pump CABG.20 Third, a high S100b
value was found in blood from a cardiotomy reservoir.8
Thus, as long as blood from a cardiotomy reservoir is
returned to a patient, the S100b level will rise gradually
during CPB.
The present study has some limitations. First, the data
of the patients undergoing HCA with or without retro-
grade cerebral perfusion are lacking. Although it is dif-
ficult to interpret the data obtained during HCA, those
obtained during reperfusion are of great importance.
Unfortunately, because we performed SCP routinely
for aortic arch repair, we have no concrete comparative
data during HCA. Second, steroid doses were not iden-
tical in the two groups and varied within the CPB group.
The administration of steroids may attenuate an in-
crease in the permeability of the BBB associated with
CPB,23 thereby reducing the leakage of S100b through
the BBB. Our previous studies also showed a large gra-
dient in proinflammatory cytokines (interleukin-8)24 or
S100b25 between cerebrospinal fluid and serum in pa-
tients undergoing thoracoabdominal aortic surgery and
given the same dose of steroids. We must take into
account that the patients in the SCP group were given a
higher dose of steroids than those in the CPB group. In
the CPB group, there was no significant difference in
arterial S100b between the patients given 500mg of
methylprednisolone and those given 2000 mg of methyl-
prednisolone at any time (data not shown). Further-
more, the larger initial dilution ratio to prime the CPB
circuit in the SCP group might result in smaller differ-
ences in the S100b levels than the true values in the two
groups, although this would affect only the intraopera-
tive data. Third, the etiology and operative procedure
were not uniform in the SCP group. There were many
variations in arterial return cannulation, cannulation for
SCP, the number of pumps used for SCP, and surgical
extension. Retrograde femoral perfusion may be re-
sponsible for brain microemboli when downstream
atherosclerosis exists.4 When arch vessels were perfused
through a balloon from its orifice, patients were ex-
posed to temporal arrest of the cerebral circulation.17
Moreover, SCP with one pump and SCP with two
pumps will have different physiological effects. In our
study, the SCP time for hemiarch replacement was
naturally shorter than that for total arch replacement
(100.2 ± 55.7 vs 149.8 ± 36.8 min, P = 0.1353); therefore,
our results warrant further investigation in animal mod-
els under uniform conditions. Fourth, the jugular
venous S100b levels were not measured in our CPB
group because our institutional review board did not
allow us to perform this invasive and expensive mea-
surement just for scientific interest. On the other hand,
we routinely insert a jugular venous oximetric catheter
for SCP, so this investigation could be performed with-
out additional risk or cost. The arterial S100b levels in
the CPB group were measured only to disclose the
brain-protective effect of SCP, which was considered a
secondary purpose of this study. Thus, we deemed our
study design to be justified.
In conclusion, the S100b levels in the jugular vein did
not provide evidence of its extracerebral source in pa-
tients without postoperative stroke. The fact that there
was no difference in S100b levels in the artery and jugu-
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lar vein indicates that there was no remarkable ischemic
insult in the SCP group, which is consistent with the
clinical outcome. The arterial S100b levels suggest that
the brain protection provided by SCP is comparable to
that provided by CPB alone in patients undergoing
CABG. Our preliminary results in this small cohort
warrant further investigation in a larger series.
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